Leaders of Shandong Refrigeration Society visited our hospital for guidance
Release time:
2022-09-03
On the morning of September 2, Kong Fanbin, Chairman of Shandong Refrigeration Society, Zhu Chuantang, Chairman of the Board of Supervisors, Li Yongan, Executive Vice President and Secretary-General, Bi Yanwen, Chairman of the Cryogenic Medical Professional Committee, Sun Wenyu, Director of Cardiac Surgery of Qilu Hospital of Shandong University (Qingdao), and Ju Xiuli, Director of Pediatrics of Qilu Hospital of Shandong University, visited the Cryogenic Medicine Center of Shandong Yinfeng Life Science Institute to understand the current development history and achievements of cryogenic medicine. Gain an in-depth understanding of Yinfeng's life extension plan and its research projects such as tissue and organ cryopreservation and resuscitation.
After the visit, the two sides had an in-depth discussion on the progress of cryogenic medical technology and conducted in-depth exchanges on future cooperation. Wang Baoqing, President of Yinfeng Biological Group, and Professor Shen Baijun, Chief Scientist, participated in the exchange forum.
Kong Fanbin, chairman of the Shandong Refrigeration Society, expressed his high appreciation for the current research results of cryogenic medicine, and also looked forward to the combination of refrigeration technology and cryogenic medical technology to provide a broader development prospect for cryogenic medical preservation technology. The experts at the meeting were full of expectations for the current research and future development of Yinfeng's life extension plan, and hoped that more industry institutions and scientific research institutes would join in the research of cryogenic medicine to help the continuous development of cryogenic medicine.
In the future, Yinfeng Cryogenic Medical Center will give full play to its own advantages, bring together the world's forces, and build a strong joint platform for industry, education and research, so that cryogenic medical technology will continue to be at the forefront of science and technology, and contribute to the continuation of human life and health.
Next article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
